We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-10.00 | -7.14% | 130.00 | 125.00 | 135.00 | 140.00 | 125.00 | 140.00 | 22,878 | 14:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -5.94 | 17.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/1/2023 19:24 | It didn’t stop some other directors LR2! | ducatiman | |
14/1/2023 17:58 | Perhaps TO has some inside information stopping him from boot filling. | lr2 | |
14/1/2023 16:46 | I do believe dibs, hallelujah! Got loads but will be adding soon. Just can’t understand why TO isn’t filling his boots. | ducatiman | |
14/1/2023 11:49 | I just think its easy to write a plan and we have no shortage of pen-pushers to fulfil that role. I’m writing a plan at the moment for a local internet thing. All the headaches and unanswered questions are about implementation. The plan looks great though and I will be doing some nice powerpoint presentations which no doubt will generate lots of encouraging noises. Some years ago the tech development innovation hub of the NHS (forget its name), issued some guff about new product introductions “at pace and scale”. I haven’t bothered to try to find any reports on how that went in different areas - partly because I think I know what I’ll find and I drink enough already. Didn’t TO came from one of those think-tank departments ? Perhaps he thought “I’ll go and make something happen” | yump | |
14/1/2023 11:22 | I’m sure with enough cliches, we’ll do ok ;-) | yump | |
14/1/2023 10:50 | It’s looking possible Dibs but the market is still unimpressed. Fingers crossed. | ducatiman | |
13/1/2023 21:39 | By 2023, diagnostic imaging networks will enable the rapid transfer of clinical images from care settings close to the patient to the relevant specialist clinician to interpret. This open standards-based infrastructure will enable both the rapid adoption of new assistive technologies to support improved and timely image reporting, as well as the development of large clinical data banks to fuel research and innovation.’ The above is not my words or any literature produced by Feedback PLC. I have extracted this from the NHS Long Term Plan which was produced in 2019. Read it carefully. It describes perfectly the functionality Bleepa provides and what it is designed to achieve. There is no other product on the market that can do exactly what Bleepa does. It has a USP. Indeed no other equivalent product is being used or piloted within the NHS. There’s no doubt that the Covid pandemic held back this transformation but it’s happening now. The above excerpt is taken from the NHS Long Term Plan issued January 2019 page 98 section 5.28 So, you read it right, 2023, this year is when it all starts to come together. | dibs61 | |
13/1/2023 17:31 | 8,882 at 95. Buy or sell? yump, you made me smile, was going to post similar. Hopefully they are thinking outside of the box and we will see some blue sky soon. | ducatiman | |
12/1/2023 17:16 | Apologies for the off topic Yump and Rag. | petekand | |
12/1/2023 15:09 | LR2 - decent tweet which I have retweeted to my millions of followers. Hopefully bringing the results announcement means we can expect good news! | digger2779 | |
12/1/2023 10:54 | Maybe. Any thoughts on why the results announcement has been moved up to 7th February from 14th February? Board leaving St. Valentine's Day free for whoopee perhaps? | lr2 | |
12/1/2023 10:44 | Nice proactive response LR2. Maybe somebody will read it. | ducatiman | |
10/1/2023 23:03 | “..QVH continues to lead the diagnostic breathlessness pathway nationally and had been applauded for work completed to date and innovation with its technical partner.” Technical partner being Bleepa/Feedback. So, perhaps a change of sentiment here and cause for optimism. The opportunity is a large one if they can capture some of this market or all of it. | petekand | |
10/1/2023 21:17 | ragnarr- I have seen these excerpts before but yes imho highly significant. QVH receiving award as a ‘major disruptor’R | dibs61 | |
10/1/2023 15:43 | And page 25Community Diagnostic Centre (CDC) We finally received confirmation on 23 December 2022 from the national team that our community diagnostic centre (CDC) business case has been approved. This means we will receive £1.937m in 2023/24 and a further £6.706m the following financial year.QVH is already a CDC, providing diagnostics for patients referred from local GP practices. The national funds will be invested in more buildings, equipment and staff to significantly expand our CDC. The further development of the CDCat QVH will mean more patients being able to have diagnostic tests nearer to home without the need to go to an acute hospital with an A&E, where emergency care can lead to delays and cancellations. | ragnarr | |
10/1/2023 14:20 | Yes they were buys. Interesting the director buys came in just before the Indian company registration. | petekand | |
10/1/2023 13:05 | Apparently the 92.999 trades were buys. So all buys so far. Vascular's find plus more CDC's being brought forward are proving to be well received. | ged5 | |
10/1/2023 13:01 | A couple of links explaining why a Foreign company should set up a private company in India. Nothing is ever obvious to me, Ducatiman. At first I thought PVT was an acronym. Interesting suggestions when doing a google search! | ged5 | |
10/1/2023 11:16 | The reason for the India co’ is obvious though. Let’s hope it reports a profit when it files its first year of trading. | ducatiman | |
10/1/2023 11:14 | I did email TO about the Bleepa Ltd co’. I think that’s what is was, asking the reason but my email remains unanswered by TO. | ducatiman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions